Lanreotide 120mg Effectiveness in Subjects With Pancreatic Neuroendocrine Tumours (PanNET) in Routine Clinical Practice.

Clinical trial NCT03947762 · TERMINATED

Trial details

NCT number: NCT03947762
Sponsor: Ipsen
Status: TERMINATED
Study type: OBSERVATIONAL

Pancreatic Neuroendocrine Tumor

Start date: 2019-07-03
Primary completion: 2021-04-30
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.